INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 1 filers reported holding INHIBRX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,000 | +9.2% | 5,181 | +54.2% | 0.00% | – |
| Q2 2023 | $87,000 | +112.2% | 3,360 | +51.0% | 0.00% | – |
| Q1 2023 | $41,000 | -67.5% | 2,225 | -56.6% | 0.00% | – |
| Q4 2022 | $126,000 | +869.2% | 5,124 | +592.4% | 0.00% | – |
| Q3 2022 | $13,000 | +116.7% | 740 | +34.8% | 0.00% | – |
| Q2 2022 | $6,000 | -87.2% | 549 | -73.9% | 0.00% | – |
| Q1 2022 | $47,000 | -82.5% | 2,100 | -65.9% | 0.00% | – |
| Q4 2021 | $269,000 | +169.0% | 6,153 | +104.6% | 0.00% | – |
| Q3 2021 | $100,000 | +53.8% | 3,007 | +29.8% | 0.00% | – |
| Q2 2021 | $65,000 | +182.6% | 2,316 | +103.5% | 0.00% | – |
| Q1 2021 | $23,000 | +21.1% | 1,138 | +97.6% | 0.00% | – |
| Q4 2020 | $19,000 | +171.4% | 576 | +49.6% | 0.00% | – |
| Q3 2020 | $7,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,023,325 | $11,615,000 | 3.23% |
| Opaleye Management Inc. | 590,000 | $6,697,000 | 3.02% |
| Sio Capital Management, LLC | 365,210 | $4,145,000 | 1.56% |
| Perceptive Advisors | 1,914,592 | $21,731,000 | 0.68% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 794,682 | $9,020,000 | 0.65% |
| Birchview Capital, LP | 70,448 | $800,000 | 0.58% |
| Meridian Wealth Advisors, LLC | 122,315 | $1,388,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 5,305,866 | $60,222,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 1,412,236 | $16,029,000 | 0.18% |
| Alaethes Wealth LLC | 19,341 | $220,000 | 0.16% |